AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Hugin Ad-hoc-Meldung nach 15 WpHG: Sonstige Inhalte: Jerini AG: Die Jerini AG legt Emissionspreis fest.

Europe Intelligence Wire

| November 01, 2005 | COPYRIGHT 2005 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From Hugin)

Ad hoc - Mitteilung verarbeitet und ubermittelt durch Hugin. Fur den Inhalt der Mitteilung ist der Emittent verantwortlich. ---------------------------------------------------------------------- -------------- Ad-hoc Meldung nach 15 WpHG

Berlin, 1. November 2005. - Die Jerini AG hat den Platzierungspreis fur ihren Borsengang gemeinsam mit den Joint Global Coordinators und Joint Bookrunners Credit Suisse First Boston und Deutsche Bank bei 3,20 Euro je Aktie festgelegt. Insgesamt wurden 15,5 Millionen Aktien aus einer Kapitalerhohung sowie weitere 0,6 Millionen Aktien aus der Mehrzuteilungs-Option zugeteilt. Vor Ausubung der Greenshoe-Option fur die erfolgte Mehrzuteilung aus der gegebenenfalls zu beschliesenden weiteren Kapitalerhohung betragt das Platzierungsvolumen 49,6 Mio. Euro. Der Nettoerlos der Transaktion fliest vollstandig dem Unternehmen zu. Zusatzinformationen: ISIN: DE0006787476 Zulassung: Amtlicher Markt / Prime Standard; Frankfurter Wertpapierborse Firmensitz: Deutschland Weitere Angaben erhalten Sie auf der Webseite von Jerini: www.jerini.de Jerini AG Stacy Wiedenmann Director Investor Relations & Corporate Communications Invalidenstr. 117 10115 Berlin Tel.: + 49 30 97893 285 Fax.: + 49 30 97893 105 wiedenmann@jerini.de Disclaimer : Diese Mitteilung und die darin enthaltenen Informationen richten sich ausschlieslich an Personen in Deutschland. Diese Veroffentlichung ist weder ein Angebot zum Verkauf noch eine Aufforderung zum Kauf von Wertpapieren. Das Angebot in Deutschland erfolgt ausschlieslich durch und auf Basis eines zu veroffentlichenden Prospekts. Der von der Bundesanstalt fur Finanzdienstleistungsaufsicht (BaFin) am 21. Oktober 2005 gebilligte Prospekt ist bei der Frankfurter Wertpapierborse, ...

Related articles from newspapers, magazines, journals, and more
Jerini AG and Merck KGaA Announce Collaboration to Develop Small Molecule...
Press release article from: Business Wire January 28, 2004 700+ words
...BUSINESS WIRE)--Jan. 28, 2004 Jerini AG and Merck KGaA today announced a collaboration...Mergener, PhD, Chief Executive Officer, Jerini AG. "It validates our novel Peptides...year over the next several years. About Jerini AG: Jerini AG (www.jerini.com) is...
Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document.
Press release article from: PR Newswire August 13, 2008 700+ words
...it has acquired 81% of the shares in Jerini AG through its wholly owned indirect subsidiary...solicitation of an offer to sell shares in Jerini AG, nor an offer to purchase or sell any...Investors and holders of shares in Jerini AG are strongly advised to read the relevant...
Jerini AG Presents Clinical Development Update for Icatibant in the Treatment...
Press release article from: PR Newswire March 6, 2006 700+ words
...Trials BERLIN, March 6 /PRNewswire-FirstCall/ -- Jerini AG (FSE: JI4) announced today that clinical trial...normal life," stated Schneider-Mergener. About Jerini AG Jerini AG is a pharmaceutical company based in Berlin, Germany...
Jerini AG Successfully Raises Additional EUR 15.5 Million to Support...
Press release article from: Business Wire February 14, 2005 700+ words
BERLIN -- Jerini AG, the Berlin-based drug discovery and development company, announced...round," said Dr. Hubert Birner, General Partner of TVM. About Jerini AG Jerini AG is a biopharmaceutical company based in Berlin, Germany focused...
Jerini AG Announces Research Collaboration with Alcon.
Press release article from: Business Wire January 19, 2005 700+ words
BERLIN, Germany -- Jerini AG has entered into a strategic discovery and development collaboration...says Adi Hoess, Chief Commercial Officer of Jerini. About Jerini AG Jerini AG (www.jerini.com) is a drug discovery and development company...
Jerini AG Presents Positive Macular Degeneration Data.
Press release article from: Business Wire April 20, 2005 700+ words
...Advancement of the Company's Compound into Clinical Trials Jerini AG, a biopharmaceutical company focused on the discovery...Head of Research and Development at Jerini. About Jerini AG Jerini AG is a biopharmaceutical company based in Berlin, Germany...
Jerini AG Completes Euro 31 Million Financing Round.
Press release article from: PR Newswire June 9, 2004 700+ words
BERLIN, June 9 /PRNewswire/ -- Jerini AG, a drug discovery and development company, announced...a strong pipeline and a convincing management." About Jerini AG Jerini AG (http://www.jerini.com/ ) is a drug discovery...
Jerini AG reports 1Q 2009 financial results.
News wire article from: Chemical Business Newsbase May 15, 2009 700+ words
Jerini AG reported financial results for 1Q ended Mar 2009. Under International Financial...amounted to EUR 0.07 for 1Q 2009, (loss/share of EUR 0.17 in 1Q 2008). Jerini AG is a pharmaceutical company based in Berlin, Germany.
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA